Home
About BioSig
Overview
Leadership
Bioelectronic Medicine
Partnerships
Pure EP
Our Solution
Publications
Physician Insights
NeuroClear
News & Media
Overview
Press Releases
BioSig in the News
Presentations
Events
CEO Blog
Investors
Investor Relations
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact
News & Media
News & Media
Overview
Press Releases
BioSig in the News
Presentations
Events
CEO Blog
BioSig in the News
Media Coverage
Q&A: Developing sensing technologies for physiological and neurological disorders
BioSig Employs Vuzix Smart Glasses in Pure EP Rollout
The Future of Medicine is Here: Bioelectronic Medicine
BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System
Westport Company May Hold Key To COVID Anti-Viral Drug
Near ‘Party Zero’ in Westport, firm tackles possible coronavirus cure
With heart surgery device selling, Westport innovator eyes wider relevance
Industry Assessment: A Roundtable of Medtech Executives
Team Up to Advance Bioelectronics
View All Media Coverage News
Video Resources
BioSig Technologies forms three new evaluation agreements for its PURE EP System
BioSig forms R&D program with Mayo Clinic to develop AI and machine learning for its PURE EP System
SumZero Headlines: Ken Londoner on Biotech Solutions in Signal Processing
The Future of Bioelectronic Medicine with Suraj Kapa, M.D.
Nasdaq Spotlight: Interview with Ken Londoner
Ken Londoner interviewed by Christine Corrado for Proactive Investors
Ken Londoner interviewed by Ray Hoffman for CEO Radio-WCBS
BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market
BioSig Technologies Inc. (OTCQB: BSGM)
View All Video Resources News
